0.00
전일 마감가:
$0.157
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$11.00M
수익:
$1.16M
순이익/손실:
$-39.74M
주가수익비율:
0.00
EPS:
-0.62
순현금흐름:
$-35.02M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
Glycomimetics Inc Stock (GLYC) Company Profile
명칭
Glycomimetics Inc
전화
240-243-1201
주소
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
GLYC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
GLYC
Glycomimetics Inc
|
0.00 | 11.00M | 1.16M | -39.74M | -35.02M | -0.62 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-14 | 개시 | Wedbush | Outperform |
2025-06-25 | 개시 | Stifel | Buy |
2025-03-21 | 개시 | Cantor Fitzgerald | Overweight |
2024-07-26 | 다운그레이드 | TD Cowen | Buy → Hold |
2023-12-22 | 개시 | CapitalOne | Overweight |
2021-11-12 | 업그레이드 | Jefferies | Hold → Buy |
2019-11-14 | 개시 | ROTH Capital | Buy |
2019-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
2019-08-05 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
2019-08-05 | 다운그레이드 | SunTrust | Buy → Hold |
2019-04-12 | 개시 | Piper Jaffray | Overweight |
2018-12-18 | 개시 | H.C. Wainwright | Buy |
2016-07-26 | 개시 | SunTrust | Buy |
2015-03-17 | 재확인 | Stifel | Buy |
모두보기
Glycomimetics Inc 주식(GLYC)의 최신 뉴스
Is GlycoMimetics Inc. a good long term investmentRapid market gains - Autocar Professional
GlycoMimetics Inc. Stock Analysis and ForecastSuperior portfolio returns - Autocar Professional
What analysts say about GlycoMimetics Inc. stockConsistent high-yield stocks - Autocar Professional
What drives GlycoMimetics Inc. stock priceRecord-breaking capital gains - jammulinksnews.com
Why GlycoMimetics Inc. stock attracts strong analyst attentionSmart Return Focused Trading - Newser
How GlycoMimetics Inc. stock performs during market volatility200 Percent Profit Outlook - Newser
What makes GlycoMimetics Inc. stock price move sharplySmart Money Trade Setups - Newser
Wedbush Initiates Crescent Biopharma at Outperform With $27 Price Target - MarketScreener
GlycoMimetics (NASDAQ:CBIO) Rating Increased to Strong-Buy at Lifesci Capital - Defense World
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 - MarketScreener
Crescent Biopharma Completes Merger with GlycoMimetics - TipRanks
Crescent Biopharma Completes Merger With GlycoMimetics - MarketScreener
Balance Sheet Dive: GlycoMimetics Inc (GLYC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Crescent Biopharma Completes Closing of Merger with GlycoMimetic - GuruFocus
Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million | CBIO Stock News - GuruFocus
Crescent Biopharma Completes Closing of Merger with - GlobeNewswire
Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced ... - Bluefield Daily Telegraph
Massive $200M Biotech Deal: Crescent Biopharma Secures Funding for Cancer Breakthrough Pipeline - Stock Titan
GlycoMimetics, Inc. Announces Board Changes - MarketScreener
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - MarketScreener
GlycoMimetics Announces Chief Executive Officer Changes - MarketScreener
GlycoMimetics (GLYC) Trading Halt Sparks Anticipation | GLYC Sto - GuruFocus
GlycoMimetics (GLYC) Trading Halt Sparks Anticipation | GLYC Stock News - GuruFocus
GlycoMimetics (NASDAQ:GLYC) Shares to Reverse Split on Monday, June 16th - Defense World
Cantor Fitzgerald Comments on GlycoMimetics FY2026 Earnings - Defense World
Where Do Analysts Think The GlycoMimetics Inc (NASDAQ: GLYC) Is Going - Stocksregister
Wellington Management Group LLP Takes Position in GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World
GlycoMimetics Stockholders Approve Merger with Crescent Biopharma - TipRanks
GlycoMimetics Stockholders Approve Proposed Merger With Crescent Biopharma And All Related Proposals - marketscreener.com
GlycoMimetics Stockholders Approve Merger with Crescent Biopharma and All Related Proposals - citybiz
GlycoMimetics (GLYC) Stockholders Approve Merger with Crescent Biopharma | GLYC Stock News - GuruFocus
GlycoMimetics announces 1-for-100 reverse stock split - Investing.com Australia
GlycoMimetics announces 1-for-100 reverse stock split By Investing.com - Investing.com Canada
Glycomimetics Inc (GLYC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):